Resources Contact Us Home
Ribonucleotide reductase inhibitors and methods of use

Image Number 10 for United States Patent #8372983.

Provided herein are novel compounds that inhibit ribonucleotide reductase (RR) by binding to RRM2 and interfering with the activity of the RRM1/RRM2 holoenzyme, as well as methods of synthesizing these novel compounds. The compounds may be used to inhibit RR activity and to treat various conditions associated with RRM2 expression, such as for example certain cancer types, mitochondrial diseases, or degenerative diseases.

  Recently Added Patents
Tablet computer
Liquid crystal display device
Noise spectrum tracking in noisy acoustical signals
Method and system for dynamic storage tiering using allocate-on-write snapshots
Bezel-less electronic display
Hand sign
Generating package profiles in software package repositories using selective subsets of packages
  Randomly Featured Patents
Stripping nucleic acids with iodine and sodium thiosulfate
Furo[3,2-b]pyridines and thieno[3,2-b]pyridines as inhibitors of leukotriene biosynthesis
Integrated circuit testing module configured for set-up and hold time testing
Thermistor composition
Method for reducing ammonia concentration in pre-combusted fuel gas using nitric oxide
Picture pickup target and reading device assembly
Fluid-encapsulating casket mattress
Herbal compositions useful in cancer treatment
Intravascular stent
Moisture detector, biological body moisture detector, natural product moisture detector, and product/material moisture detector